Takenaka K - Search Results

1

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.

Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI, Dick JE, Danska JS. Takenaka K, et al. Nat Immunol. 2007 Dec;8(12):1313-23. doi: 10.1038/ni1527. Epub 2007 Nov 4. Nat Immunol. 2007. PMID: 17982459

2

Low rhodamine 123 retention identifies long-term human hematopoietic stem cells within the Lin-CD34+CD38- population.

McKenzie JL, Takenaka K, Gan OI, Doedens M, Dick JE. McKenzie JL, et al. Among authors: takenaka k. Blood. 2007 Jan 15;109(2):543-5. doi: 10.1182/blood-2006-06-030270. Epub 2006 Sep 21. Blood. 2007. PMID: 16990597 Free article.

3

Stem cell gene expression programs influence clinical outcome in human leukemia.

Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P, Metzeler KH, Poeppl A, Ling V, Beyene J, Canty AJ, Danska JS, Bohlander SK, Buske C, Minden MD, Golub TR, Jurisica I, Ebert BL, Dick JE. Eppert K, et al. Among authors: takenaka k. Nat Med. 2011 Aug 28;17(9):1086-93. doi: 10.1038/nm.2415. Nat Med. 2011. PMID: 21873988

4

Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells.

Warner JK, Wang JC, Takenaka K, Doulatov S, McKenzie JL, Harrington L, Dick JE. Warner JK, et al. Among authors: takenaka k. Leukemia. 2005 Oct;19(10):1794-805. doi: 10.1038/sj.leu.2403917. Leukemia. 2005. PMID: 16094415

5

Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition.

Dorrell C, Takenaka K, Minden MD, Hawley RG, Dick JE. Dorrell C, et al. Among authors: takenaka k. Mol Cell Biol. 2004 Aug;24(16):6993-7002. doi: 10.1128/MCB.24.16.6993-7002.2004. Mol Cell Biol. 2004. PMID: 15282300 Free PMC article.

6

[Xenotransplantation assay for cancer stem cells].

Takenaka K. Takenaka K. Nihon Rinsho. 2015 May;73(5):756-64. Nihon Rinsho. 2015. PMID: 25985627 Japanese.

7

[Progress in xenotransplantation model for human hematopoietic stem cell assay].

Takenaka K. Takenaka K. Rinsho Ketsueki. 2012 Oct;53(10):1826-37. Rinsho Ketsueki. 2012. PMID: 23037758 Review. Japanese. No abstract available.

8

Inadequate Efficacy of Biologics for Treating Proximal Ileal Lesions in Crohn's Disease; a prospective multicenter study.

Takenaka K, Hisamatsu T, Kobayashi T, Yamamoto H, Ohmiya N, Hayashi R, Matsuoka K, Saruta M, Andoh A, Fukata N, Watanabe K, Imaeda H, Hirai F, Matsumoto T, Hirakawa A, Yano T, Matsuura M, Okamoto R, Ohtsuka K, Watanabe M. Takenaka K, et al. Clin Gastroenterol Hepatol. 2024 Dec 16:S1542-3565(24)01084-X. doi: 10.1016/j.cgh.2024.10.030. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39694212

9

JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN).

Takahashi N, Takenaka K, Iriyama N, Kirito K, Kawaguchi T, Kimura S, Shimoda K. Takahashi N, et al. Among authors: takenaka k. Int J Hematol. 2024 Nov 26. doi: 10.1007/s12185-024-03865-2. Online ahead of print. Int J Hematol. 2024. PMID: 39589695 No abstract available.

10

Triple immunostaining demonstrates the possible existence of segregated-nucleus-containing atypical monocytes in human primary myelofibrosis bone marrow: a case report.

Homma S, Ogasawara T, Suga M, Nakamura Y, Takenaka K, Marshall S, Kawauchi K, Mori N, Kuroda H, Nakamura N, Miyagi Y, Masunaga A. Homma S, et al. Among authors: takenaka k. J Med Case Rep. 2024 Oct 30;18(1):510. doi: 10.1186/s13256-024-04844-1. J Med Case Rep. 2024. PMID: 39472997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,144 results

Search Page

Filters